Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

NCT07096063 · clinicaltrials.gov ↗

COMPLETED

Status

887132

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Overweight
Cardiovascular (CV) Risk

Interventions

DRUG: Tirzepatide
DRUG: Dulaglutide
DRUG: Semaglutide
DRUG: Sitagliptin

Sponsor

Brigham and Women's Hospital